OBGYN Reveals How Medicine Is Failing Women's Health & Hormones | Dr. Mary Claire Haver EP 919
Board-certified OBGYN Dr. Mary Claire Haver exposes the shocking truth about menopause treatment failures in modern medicine, revealing how women have been excluded from clinical research and why early hormone replacement therapy can slash cardiovascular disease risk by 50% - essential knowledge for women over 40 navigating midlife health changes.
Audio is streamed directly from the publisher (pdst.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Don't miss the Make Money Easy Book Tour! https://lewishowes.com/moneyyou
Check out the full episode: greatness.lnk.to/1742
"Every clinician who touches a woman should have required menopause training. Not just hot flashes, night sweats, and what HRT may or may not do for you, but how our sex differs in disease and how we need to treat women differently." - Dr. Mary Claire Haver
Dr. Mary Claire Haver shines a light on the alarming gaps in women's healthcare, particularly during menopause. With shocking revelations about how medical research has historically excluded women—legally until 1993—she exposes why treatments like statins are prescribed to menopausal women despite no evidence they reduce heart attack risk in female patients. As a physician who received just one hour of menopause training in medical school, Dr. Haver's advocacy through The Meno Posse fights for legislative changes and proper medical education about women's unique health needs.
The conversation explores how menopause dramatically increases cardiovascular disease risk by 50% compared to premenopausal women of the same age, with estrogen playing a crucial protective role for heart vessels. Dr. Haver challenges the medical system's approach of treating women as "little men with breasts and a uterus" rather than recognizing fundamental biological differences in disease presentation and treatment requirements. Her insights reveal why hormone replacement therapy started early enough can cut cardiovascular disease risk by half each year.
Sign up for the Greatness newsletter: http://www.greatness.com/newsletter
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.